Related references
Note: Only part of the references are listed.Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma
Marc de Perrot et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2020)
Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
Gavitt A. Woodard et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Tumour predisposition and cancer syndromes as models to study gene-environment interactions
Michele Carbone et al.
NATURE REVIEWS CANCER (2020)
A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce
Joseph S. Friedberg et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
Michele Carbone et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy
Anna Elisabeth Frick et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2019)
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma
Bryan M. Burt et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Radiotherapy for the treatment of malignant pleural mesothelioma
Marc de Perrot et al.
LANCET ONCOLOGY (2017)
In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model
Luis De La Maza et al.
CLINICAL CANCER RESEARCH (2017)
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
Valerie W. Rusch et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial
Rolf A. Stahel et al.
LANCET ONCOLOGY (2015)
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy
B. C. John Cho et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
Rea Federico et al.
BMC CANCER (2013)
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass
Valerie Rusch et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
Tom Treasure et al.
LANCET ONCOLOGY (2011)
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial
P. E. Van Schil et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma
Marc de Perrot et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma
Lee M. Krug et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors
Tristan D. Yan et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study
Tamara R. Tilleman et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma
Marc de Perrot et al.
ANNALS OF THORACIC SURGERY (2008)
The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the American Joint Committee on Cancer staging system
Raja M. Flores et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma
W. Weder et al.
ANNALS OF ONCOLOGY (2007)
Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma
Marc de Perrot et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2007)
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma
WG Richards et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma
VW Rusch et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Share Paper
